The European Patent Office published patent application EP3972422A1 on March 25, 2026, covering dietary butyrate compositions for therapeutic uses. The patent application by Nestlé (Société des Produits Nestlé S.A.) includes claims for butyric acid derivatives and compositions for treating digestive disorders and metabolic conditions. IPC classifications span food compositions (A23K, A23L) and therapeutic applications (A61P), with designated states covering all major European patent jurisdictions.

This is a standard patent publication providing intellectual property protection rather than imposing regulatory obligations. No compliance actions are required. Companies in the pharmaceutical or functional food sectors should note this patent grant for freedom-to-operate considerations in R&D and product development involving butyrate-based therapeutic compositions.